Active, Not Recruiting
A Biomarker Study to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma
NCT07063758
- Conditions
- Advanced Urothelial Carcinoma
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan